1	Paciente	paciente	NCCS000	C0030705	persona	0-8	678_QUEST_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0332285	atributo	9-11	678_QUEST_clinical_caseMIR	SENT1	-	-
3	67	67		-	-	12-14	678_QUEST_clinical_caseMIR	SENT1	-	-
4	años	año	NCMP000	C0439234	calificador	15-19	678_QUEST_clinical_caseMIR	SENT1	-	-
5	que	que	PR0CN000	-	-	20-23	678_QUEST_clinical_caseMIR	SENT1	-	-
6	en	en	SPS00	C1720294#C0332285	calificador#atributo	24-26	678_QUEST_clinical_caseMIR	SENT1	-	-
7	los	el	DA0MP0	-	-	27-30	678_QUEST_clinical_caseMIR	SENT1	-	-
8	últimos	último	AO0MP0	-	-	31-38	678_QUEST_clinical_caseMIR	SENT1	-	-
9	6	6		-	-	39-40	678_QUEST_clinical_caseMIR	SENT1	-	-
10	meses	mes	NCMP000	C0439231	calificador	41-46	678_QUEST_clinical_caseMIR	SENT1	-	-
11	,	,	Fc	-	-	46-47	678_QUEST_clinical_caseMIR	SENT1	-	-
12	en	en	SPS00	C1720294#C0332285	calificador#atributo	48-50	678_QUEST_clinical_caseMIR	SENT1	-	-
13	dos	dos		-	-	51-54	678_QUEST_clinical_caseMIR	SENT1	-	-
14	analíticas	analítica	NCFP000	-	-	55-65	678_QUEST_clinical_caseMIR	SENT1	-	-
15	de	de	SPS00	C0332285	atributo	66-68	678_QUEST_clinical_caseMIR	SENT1	-	-
16	rutina	rutina	NCFS000	C0035976#C0205547	sustancia#producto#calificador	69-75	678_QUEST_clinical_caseMIR	SENT1	-	-
17	,	,	Fc	-	-	75-76	678_QUEST_clinical_caseMIR	SENT1	-	-
18	presenta	presentar	VMIP3S0	-	-	77-85	678_QUEST_clinical_caseMIR	SENT1	-	-
19	linfocitosis	linfocitosis	NCFN000	C0024282#C0853698	trastorno#hallazgo	86-98	678_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
20	progresiva	progresivo	AQ0FS0	C0205329	calificador	99-109	678_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
21	.	.	Fp	-	-	109-110	678_QUEST_clinical_caseMIR	SENT1	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	111-113	678_QUEST_clinical_caseMIR	SENT2	-	-
2	la	el	DA0FS0	-	-	114-116	678_QUEST_clinical_caseMIR	SENT2	-	-
3	última	último	AO0FS0	-	-	117-123	678_QUEST_clinical_caseMIR	SENT2	-	-
4	,	,	Fc	-	-	123-124	678_QUEST_clinical_caseMIR	SENT2	-	-
5	hemoglobina	hemoglobina	NCFS000	C0019046	sustancia	125-136	678_QUEST_clinical_caseMIR	SENT2	-	-
6	15,4	15.4	Z	-	-	137-141	678_QUEST_clinical_caseMIR	SENT2	-	-
7	g	g	NCMN000	-	-	142-143	678_QUEST_clinical_caseMIR	SENT2	-	-
8	/	/	Fh	-	-	143-144	678_QUEST_clinical_caseMIR	SENT2	-	-
9	dl	decilitro	NCMN000	C0439241	calificador	144-146	678_QUEST_clinical_caseMIR	SENT2	-	-
10	;	;	Fx	-	-	146-147	678_QUEST_clinical_caseMIR	SENT2	-	-
11	leucocitos	leucocito	NCMP000	C0023516	célula	148-158	678_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
12	18,5	18,5		-	-	159-163	678_QUEST_clinical_caseMIR	SENT2	-	-
13	x103/μL	x103/μL		-	-	164-171	678_QUEST_clinical_caseMIR	SENT2	-	-
14	con	con	SPS00	C0332287	atributo	172-175	678_QUEST_clinical_caseMIR	SENT2	-	-
15	82	82	Z	-	-	176-178	678_QUEST_clinical_caseMIR	SENT2	-	-
16	%	%	Ft	-	-	179-180	678_QUEST_clinical_caseMIR	SENT2	-	-
17	de	de	SPS00	C0332285	atributo	181-183	678_QUEST_clinical_caseMIR	SENT2	-	-
18	linfocitos	linfocito	NCMP000	C0024264	célula	184-194	678_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
19	maduros	maduro	AQ0MP0	C0205286	calificador	195-202	678_QUEST_clinical_caseMIR	SENT2	-	-
20	que	que	PR0CN000	-	-	203-206	678_QUEST_clinical_caseMIR	SENT2	-	-
21	por	por	SPS00	C0678226	atributo	207-210	678_QUEST_clinical_caseMIR	SENT2	-	-
22	citometría	citometría		C0016263_1	procedimiento_1	211-221	678_QUEST_clinical_caseMIR	SENT2	-	-
23	de	de	SPS00	C0016263_2	procedimiento_2	222-224	678_QUEST_clinical_caseMIR	SENT2	-	-
24	flujo	flujo	NCMS000	C0016263_3	procedimiento_3	225-230	678_QUEST_clinical_caseMIR	SENT2	-	-
25	expresan	expresar	VMIP3P0	-	-	231-239	678_QUEST_clinical_caseMIR	SENT2	-	-
26	los	el	DA0MP0	-	-	240-243	678_QUEST_clinical_caseMIR	SENT2	-	-
27	antígenos	antígeno	NCMP000	C0003320	sustancia	244-253	678_QUEST_clinical_caseMIR	SENT2	-	-
28	CD5/CD19/CD23	CD5/CD19/CD23		-	-	254-267	678_QUEST_clinical_caseMIR	SENT2	-	-
29	y	y	CC	C1706368	calificador	268-269	678_QUEST_clinical_caseMIR	SENT2	-	-
30	plaquetas	plaqueta	NCFP000	C0005821	estructura_corporal	270-279	678_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
31	240	240		-	-	280-283	678_QUEST_clinical_caseMIR	SENT2	-	-
32	x103/μL	x103/μL		-	-	284-291	678_QUEST_clinical_caseMIR	SENT2	-	-
33	.	.	Fp	-	-	291-292	678_QUEST_clinical_caseMIR	SENT2	-	-

1	¿	¿	Fia	-	-	293-294	678_QUEST_clinical_caseMIR	SENT3	-	-
2	Qué	qué	DT0CN0	-	-	294-297	678_QUEST_clinical_caseMIR	SENT3	-	-
3	actitud	actitud	NCFS000	C0004271	entidad_observable	298-305	678_QUEST_clinical_caseMIR	SENT3	-	-
4	le	le	PP3CSD00	C1292157#C0409974	hallazgo#trastorno	306-308	678_QUEST_clinical_caseMIR	SENT3	-	-
5	parece	parecer	VMIP3S0	-	-	309-315	678_QUEST_clinical_caseMIR	SENT3	-	-
6	correcta	correcto	AQ0FS0	C0205170	calificador	316-324	678_QUEST_clinical_caseMIR	SENT3	-	-
7	?	?	Fit	-	-	324-325	678_QUEST_clinical_caseMIR	SENT3	-	-
8	:	:	Fd	-	-	325-326	678_QUEST_clinical_caseMIR	SENT3	-	-
9	.	.	Fp	-	-	326-327	678_QUEST_clinical_caseMIR	SENT3	-	-

